Loading clinical trials...
Loading clinical trials...
Effect of Pioglitazone on Mitochondrial Metabolism in Pulmonary Hypertension Due to Chronic Lung Disease
Conditions
Interventions
Pioglitazone 30mg
Placebo
+1 more
Locations
1
United States
Emory Healthcare System
Atlanta, Georgia, United States
Start Date
December 17, 2024
Primary Completion Date
February 1, 2028
Completion Date
February 1, 2028
Last Updated
July 3, 2025
NCT05746039
NCT07073820
NCT03854071
NCT07477197
NCT06899815
NCT07120789
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions